# Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry

> **NCT03075215** · — · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 2044 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Device Programming of the Boston Scientific Cardiac Resynchronization Therapy Defibrillator (CRT-D)

## Key facts

- **NCT ID:** NCT03075215
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-14
- **Primary completion:** 2021-11-15
- **Final completion:** 2021-11-15
- **Target enrollment:** 2044 (ACTUAL)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03075215

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03075215, "Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03075215. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*